Chewy slammed by analyst downgrades as growth doubts mount
The gist
Chewy’s shares took a nosedive as analyst downgrades and fresh doubts about its growth and profitability sent investor confidence packing.
What to know
- JP Morgan’s Doug Anmuth downgraded Chewy to “Neutral” and slashed the price target to $24 on September 12, triggering a sharp 5.6% drop in the stock that day.
- Investors are worried about Chewy’s slowing sales, with only 7.1% CAGR over three years and just 6.8% expected revenue growth in the coming year.
- Recent profitability was juiced by one-off gains, not lasting improvements, raising concerns about the company’s thin 29.6% gross margin and competitive pressures.
Wall Street Confidence Shaken
Chewy’s sharp stock drop after a single analyst downgrade signaled a rapid shift in investor sentiment, revealing deepening market skepticism that had been building beneath the surface.
The clearest sign that sentiment had turned came on September 12, when JP Morgan’s Doug Anmuth downgraded Chewy to “Neutral” and cut his price target to $24, a combination that immediately translated into market damage rather than a muted response. Shares slid 5.6% that day, showing that investors were not treating the call as an isolated opinion but as confirmation that Wall Street’s confidence in the stock had become materially more fragile over a compressed mid-September window.
What made the move notable was not just the downgrade itself, but the speed with which it fed into the stock’s repricing, reinforcing the sense that caution around Chewy had intensified between September 10 and 14. A target cut from a major bank and a same-day 5.6% drop signaled a market newly willing to mark down the shares on negative analyst revisions, suggesting that skepticism had become the dominant lens through which investors were interpreting the company.
Growth Worries Intensify
Investors are losing patience with Chewy’s sluggish sales and razor-thin margins, as repeated analyst target cuts highlight doubts about the company’s ability to deliver sustainable, organic growth.
Skepticism around Chewy stems less from a sudden operational break than from a longer slowdown that headline revenue has not fully masked. One August review called the company’s top-line path “tepid,” saying Chewy’s sales grew at a 7.1% compounded annual growth rate over the last three years and that analysts expect revenue to rise 6.8% over the next 12 months, which suggests organic growth is modest and unlikely, by itself, to justify a richer valuation.
That concern is meeting a margin profile many investors already view as constrained by competition and cost intensity. One analysis said Chewy averaged a 29.6% gross margin over the last two years and had to pay $70.42 to service providers for every $100 in revenue, while later reports argued recent profitability was helped by timing benefits, tariff refunds, rebate shifts, and other one-time items rather than durable improvement.
By late August and into September, the market was repricing expectations ahead of results rather than reacting to a fresh business collapse. On August 26, one analysis said Chewy (CHWY) was down 5.9% after a fresh analyst price-target cut from Morgan Stanley, even though first-quarter 2026 net sales rose 7.7% year over year and adjusted EBITDA margin was 7.5%; Chewy had said on August 19 it would report on September 9, and Morgan Stanley cut its target to $37, reinforcing concern about slowing organic demand, pressured discretionary pet spending, and margin sustainability.
